
Epion Therapeutics is a clinical-stage ophthalmology company developing an innovative epithelium-on treatment for keratoconus. Epion's drug-device combination, EpiSmart, is currently in Phase 3 trials at over 20 US clinical sites.
Address
BurlingtonMA
United States